A patient needed a costly drug. He thought a copay card would help — then the bill came

Jayant Mishra said he was approved for a copay card covering $9,450 a year. He didn't realize how fast the money would run out.

Two major drug companies are the latest to join TrumpRx

President Donald Trump is pushing ahead with announcements to TrumpRx.gov as Americans look for ways to cut costs associated ...
The Union Democrat

Bill of the Month: He needs an expensive drug. A copay card helped — until it didn’t

Over the course of 2025, Jayant Mishra of Mission Viejo, California, progressively developed scaly, itchy red patches on his ...
India Currents on MSN

Jayesh Mishra thought a co-pay card would cover expensive medication: then the bills came

Over the course of 2025, Jayant Mishra of Mission Viejo, California, progressively developed scaly, itchy red patches on his skin. Then came the pain and swelling in the joints of […] ...

GLP-1 drugs like Ozempic can raise bone and tendon injury risk, study suggests

New research suggests GLP-1 drugs may increase the risk of bone and tendon injuries and other conditions, including ...
The New Yorker

Can a “Living Drug” Cure Autoimmune Diseases?

A “living drug” was developed as a cancer treatment. Now it is showing promise for conditions, such as lupus and multiple sclerosis, that have long been considered incurable.
Healthline

Ozempic, Wegovy May Help Reverse Damage Caused by Osteoarthritis

A new study reports that GLP-1 semaglutide medications may help reverse the effects of osteoarthritis in the joints by ...
Medical Marketing & Media

He needs an expensive drug. A copay card helped — until it didn’t.

Using a copay card has gotten trickier as insurers push back. First, patients need to understand whether there is an annual dollar or time limit on the card and how it works with their insurance.
Wall Street Journal

Novo Nordisk to Cut U.S. List Prices for Ozempic, Wegovy by Up to 50%

Novo Nordisk NOVO.B5.96%increase; green up pointing triangle plans to slash U.S. list prices for its popular weight-loss and diabetes drugs Wegovy and Ozempic by up to half starting next year. Under ...